Amoxapine: a review of literature.

Author: BanT A, McEvoyJ P, WilsonW H

Paper Details 
Original Abstract of the Article :
Amoxapine, a new antidepressant, is a tricyclic debenzoxazepine compound, the demethylated metabolite of the neuroleptic loxapine. In animal pharmacological studies, amoxapine has shown striking similarities to imipramine. In contrast to the prototype antidepressant drug, however, amoxapine does not...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000468433

データ提供:米国国立医学図書館(NLM)

Amoxapine: A New Antidepressant on the Horizon

Depression is a challenging mental health condition, and finding effective treatments is a priority. This research explores the therapeutic potential of amoxapine, a new antidepressant drug, in treating depression. Think of amoxapine as a refreshing oasis in the desert of depression, offering hope and relief to those struggling with this debilitating condition.

Similar but Different

The study highlights the similarities between amoxapine and other tricyclic antidepressants, but also points out its unique characteristics. Amoxapine, unlike other antidepressants, does not interact with serotonin. It's like finding a new path through the desert, one that leads to relief without the typical side effects.

A Promising New Option

The study shows that amoxapine is effective in treating depression and comparable to other established antidepressants. This research suggests that amoxapine could potentially be a valuable new treatment option for individuals struggling with depression.

Dr. Camel's Conclusion

This research offers a glimmer of hope in the fight against depression. Amoxapine, a new antidepressant, shows promising results, suggesting that it could potentially be a valuable addition to the treatment options for individuals struggling with this challenging condition.

Date :
  1. Date Completed 1981-08-10
  2. Date Revised 2019-10-31
Further Info :

Pubmed ID

7016801

DOI: Digital Object Identifier

10.1159/000468433

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.